Cu Nguyen Selected Research

Neoplasms (Cancer)

1/2021	Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.
1/2021	A comprehensive map of alternative polyadenylation in African American and European American lung cancer patients.
1/2021	Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.
12/2018	CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer.
3/2018	Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.
10/2017	A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.
11/2016	Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group.
2/2015	Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.
2/2011	The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells.
5/2009	Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cu Nguyen Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 05/2004
3	Disease Progression 01/2020 - 05/2004
3	Colonic Neoplasms (Colon Cancer) 09/2005 - 08/2004
3	Asthma (Bronchial Asthma) 11/2003 - 11/2002
2	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2012 - 08/2010
2	Inflammation (Inflammations) 02/2003 - 11/2002
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Aneuploidy (Aneuploid) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Triple Negative Breast Neoplasms 12/2018
1	Carcinogenesis 03/2018
1	Adenocarcinoma 03/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2018
1	Anaplasia 11/2016
1	Infarction (Infarctions) 01/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2011
1	Fibrosis (Cirrhosis) 08/2010
1	Colorectal Neoplasms (Colorectal Cancer) 05/2009
1	Alzheimer Disease (Alzheimer's Disease) 08/2005
1	Carcinoma (Carcinomatosis) 08/2004
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 08/2004
1	Hypertension (High Blood Pressure) 05/2004
1	Edema (Dropsy) 02/2003
1	Eosinophilia 11/2002

Drug/Important Bio-Agent (IBA)

6	ICG 001IBA 12/2018 - 08/2004
5	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2015
5	CateninsIBA 12/2018 - 02/2011
5	beta CateninIBA 08/2010 - 08/2004
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2016
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2017
3	SurvivinIBA 03/2018 - 05/2005
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 03/2018
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 03/2018 - 08/2010
2	Carrier Proteins (Binding Protein)IBA 03/2018 - 08/2010
2	Proteins (Proteins, Gene)FDA Link 11/2016 - 05/2005
2	NucleotidesIBA 02/2015 - 05/2004
2	TCF Transcription FactorsIBA 08/2010 - 08/2005
2	NF-kappa B (NF-kB)IBA 02/2003 - 11/2002
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 02/2003 - 11/2002
1	Formaldehyde (Formol)FDA Link 01/2021
1	ParaffinIBA 01/2021
1	Poly AIBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	Gemcitabine FDA Link 03/2018
1	CollagenIBA 03/2012
1	gamma Catenin (Plakoglobin)IBA 02/2011
1	CREB-Binding ProteinIBA 08/2010
1	Bleomycin (Blenoxane)FDA LinkGeneric 08/2010
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2009
1	LigandsIBA 05/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009
1	Cyclin D1IBA 09/2005
1	Nerve Growth Factor (NGF)IBA 08/2005
1	Oxidoreductases (Dehydrogenase)IBA 11/2003
1	PNRI299IBA 02/2003
1	Interleukin-4 (Interleukin 4)IBA 02/2003
1	Transcription Factors (Transcription Factor)IBA 02/2003
1	MOL 294IBA 11/2002
1	AntioxidantsIBA 11/2002
1	Oxidants (Oxidizing Agents)IBA 11/2002
1	Interleukin-13IBA 11/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2018
1	Drug Therapy (Chemotherapy) 12/2018